rs121918687
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_001354712.2(THRB):c.1358C>T(p.Pro453Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P453H) has been classified as Pathogenic.
Frequency
Consequence
NM_001354712.2 missense
Scores
Clinical Significance
Conservation
Publications
- thyroid hormone resistance, generalized, autosomal dominantInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- resistance to thyroid hormone due to a mutation in thyroid hormone receptor betaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- thyroid hormone resistance, generalized, autosomal recessiveInheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
THRB | NM_001354712.2 | c.1358C>T | p.Pro453Leu | missense_variant | Exon 11 of 11 | ENST00000646209.2 | NP_001341641.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Thyroid hormone resistance, generalized, autosomal dominant Pathogenic:1
Variant summary: THRB c.1358C>T (p.Pro453Leu) results in a non-conservative amino acid change located in the ligand-binding domain (IPR000536) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251490 control chromosomes (gnomAD). c.1358C>T has been reported in the literature in three individuals (two siblings and their father) affected with Thyroid Hormone Resistance and was found to segregate with the disease phenotype in this family in an autosomal dominant pattern (Rivolta_2009, Chiesa_2012). These data indicate that the variant is likely associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function and found the variant had a reduced affinity for T3 and resulted in a decreased induction of expression from T3 response elements compared to the WT protein (Zavacki_1993). Additionally, several variants affecting the same amino acid (Pro453Ser, Pro453Thr, Pro453Ala) have been classified as pathogenic, suggesting Pro453 is important for protein function. The following publications have been ascertained in the context of this evaluation (PMID: 21870171, 19268523, 8264663). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at